-

Spondyloarthritis (Spondyloarthropathy) Global Clinical Trials Review 2025: Country (G7 & E7), Phase, Trial Status, End Points Status and Sponsor Type - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Spondyloarthritis (Spondyloarthropathy) - Global Clinical Trials Review, 2025" clinical trials report has been added to ResearchAndMarkets.com's offering.

The report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. The report also provides prominent drugs for in-progress trials (based on number of ongoing trials).

The analyst Clinical Trial Reports are generated using the analyst's proprietary database - Pharma - Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Report Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to Buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Key Topics Covered:

  • Report Guidance
  • The analyst Clinical Trials Report Coverage
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
  • Top Five Countries Contributing to Clinical Trials in Europe
  • Top Countries Contributing to Clinical Trials in North America
  • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Spondyloarthritis (Spondyloarthropathy) to Musculoskeletal Disorders Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Spondyloarthritis (Spondyloarthropathy) to Musculoskeletal Disorders Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
  • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
  • Top Companies Participating in Spondyloarthritis (Spondyloarthropathy) Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Spondyloarthritis (Spondyloarthropathy)
  • Oct 24, 2025: Spyre Therapeutics Announces Poster Presentations at American College of Rheumatology (ACR) Convergence 2025
  • Clinical Trial Profile Snapshots
  • Appendix

Companies Featured

  • Novartis AG
  • AbbVie Inc
  • GSK plc
  • Johnson & Johnson
  • Merck & Co Inc
  • Pfizer Inc
  • Zhuhai Rundu Pharmaceutical Co Ltd
  • Eli Lilly and Co
  • Asia Pharmaceutical Group (Hainan) Co Ltd
  • Nanjing Easeheal Pharmaceutical Co Ltd

For more information about this clinical trials report visit https://www.researchandmarkets.com/r/n4nhln

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Neighborhood Electric Vehicles Market Research 2025: Focus on Key Emerging Technologies, Autonomous Charging, 3D EV Printing, and V2G EV Charging Stations - Forecast to 2030 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Neighborhood Electric Vehicles Market" report has been added to ResearchAndMarkets.com's offering. The global automotive industry is transitioning significantly from producing gas-powered vehicles to EVs. While EVs have been in the market for a long time, advances in technological innovation and an inclination toward green mobility solutions have substantially fueled their global demand. NEVs are part of EVs, which are ideal for the worldwide shift toward clean tra...

AI in Agriculture Global Markets Report 2025-2030, Profiles of Leading Players - Microsoft, IBM, Deere & Co., Syngenta and Bayer CropScience - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "AI in Agriculture: Global Markets" report has been added to ResearchAndMarkets.com's offering. The global market for AI in agriculture is estimated to grow from $2.8 billion in 2025 to reach $8.5 billion by the end of 2030, at a compound annual growth rate (CAGR) of 25.1% from 2025 through 2030. The agriculture industry is experiencing a major revolution due to widespread AI adoption along its entire value chain. AI has shifted from a futurist concept to a crucial...

Machine Vision-2D and 3D MV Systems Technologies and Markets Report 2025-2030, Profiles of Leading Players - Cognex., Keyence., Teledyne, Basler, and Omron - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Machine Vision-2D and 3D MV Systems: Technologies and Markets" report has been added to ResearchAndMarkets.com's offering. The global market for machine vision (MV) systems is expected to grow from $15.9 billion in 2025 and is projected to reach $24.6 billion by the end of 2030, at a compound annual growth rate (CAGR) of 9.1% during the forecast period of 2025 to 2030. The report provides a comprehensive regional analysis covering North America, Europe, Asia-Pacifi...
Back to Newsroom